Press Releases

• Dec. 4, 2023

  Notable Labs to Participate in JMP Securities Hematology and Oncology Summit

• Nov. 14, 2023

  Notable Labs Announces Filing of Form 10-Q for Third Quarter 2023

• Nov. 9, 2023

  Notable Labs Announces JCO Precision Oncology Publication Demonstrating PPMP Potential to Identify Novel Drug Combinations in JMML

• Oct. 16, 2023

  Notable Labs Closes Merger Transaction With VBL Therapeutics

• Jun. 9, 2023

  Notable Labs Presents Data Demonstrating PPMP’s Potential to Identify Novel Drug Combinations in JMML at the 2023 EHA Hybrid Congress

• Apr. 18, 2023

  Notable Labs Presents Clinical Platform Validation Data at the 2023 AACR Conference

• Feb. 23, 2023

  VBL Therapeutics and Notable Labs Announce Definitive Merger Agreement

• Jun. 10, 2021

  Notable Labs to Attend BIO Digital 2021 Highlighting Predictive Technology Platform for Oncology

• Mar. 31, 2021

  Notable Names Dr. Thomas A. Bock as CEO

• Jan. 26, 2021

  Notable Labs to Present Analysis of Hematologic Oncology Drug Sensitivity Data